Mucoadhesive ocular insert based on thiolated poly(acrylic acid):: development and in vivo evaluation in humans

被引:122
作者
Hornof, M
Weyenberg, W
Ludwig, A
Bernkop-Schnürch, A
机构
[1] Univ Vienna, Inst Pharmaceut Technol & Biopharmaceut, A-1090 Vienna, Austria
[2] Croma Pharma GmbH, A-2100 Leobendorf, Austria
[3] Univ Antwerp, Lab Pharmaceut Technol & Biopharm, B-2610 Antwerp, Belgium
关键词
ocular insert; ocular drug delivery; poly(acrylic acid)-cysteine conjugate; thiomers; fluorophotometry; in vivo; diclofenac; DELIVERY SYSTEM; NANOPARTICLES; MICROSPHERES; RELEASE; SURFACE; VITRO;
D O I
10.1016/S0168-3659(03)00135-4
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The aim of the study was to develop a mucoadhesive ocular insert for the controlled delivery of ophthalmic drugs and to evaluate its efficacy in vivo. The inserts tested were based either on unmodified or thiolated poly(acrylic acid). Water uptake and swelling behavior of the inserts as well as the drug release rates of the model drugs fluorescein and two diclofenac salts with different solubility properties were evaluated in vitro. Fluorescein was used as fluorescent tracer to study the drug release from the insert in humans. The mean fluorescein concentration in the comea/tearfilm compartment as a function of time was determined after application of aqueous eye drops and inserts composed of unmodified and of thiolated poly(acrylic acid). The acceptability of the inserts by the volunteers was also evaluated. Inserts based on thiolated poly(acrylic acid) were not soluble and had good cohesive properties. A controlled release was achieved for the incorporated model drugs. The in vivo study showed that inserts based on thiolated poly(acrylic acid) provide a fluorescein concentration on the eye surface for more than 8 h, whereas the fluorescein concentration rapidly decreased after application of aqueous eye drops or inserts based on unmodified poly(acrylic acid). Moreover, these inserts were well accepted by the volunteers. The present study indicates that ocular inserts based on thiolated poly(acrylic acid) are promising new solid devices for ocular drug delivery. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:419 / 428
页数:10
相关论文
共 35 条
[1]   Epithelial mucins of the ocular surface:: Structure, biosynthesis and function [J].
Argüeso, P ;
Gipson, IK .
EXPERIMENTAL EYE RESEARCH, 2001, 73 (03) :281-289
[2]   Adverse effects of topical antiglaucoma drugs on the ocular surface [J].
Arici, MK ;
Arici, DS ;
Topalkara, A ;
Güler, C .
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2000, 28 (02) :113-117
[3]  
Baeyens V, 1997, Pharm Acta Helv, V72, P191
[4]  
Baudouin C, 1996, Curr Opin Ophthalmol, V7, P80, DOI 10.1097/00055735-199604000-00014
[5]   Development of controlled drug release systems based on thiolated polymers [J].
Bernkop-Schnürch, A ;
Scholler, S ;
Biebel, RG .
JOURNAL OF CONTROLLED RELEASE, 2000, 66 (01) :39-48
[6]   Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin [J].
Cavalli, R ;
Gasco, MR ;
Chetoni, P ;
Burgalassi, S ;
Saettone, MF .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 238 (1-2) :241-245
[7]   Evaluation of a mucoadhesive tablet for ocular use [J].
Ceulemans, J ;
Vermeire, A ;
Adriaens, E ;
Remon, JP ;
Ludwig, A .
JOURNAL OF CONTROLLED RELEASE, 2001, 77 (03) :333-344
[8]   In vitro and in vivo evaluation of an ocular delivery system of 5-fluorouracil microspheres [J].
Chiang, CH ;
Tung, SM ;
Lu, DW ;
Yeh, MK .
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2001, 17 (06) :545-553
[9]  
Chickering DE, 1999, DRUGS PHARM SCI, V98, P1
[10]   A novel in situ-forming ophthalmic drug delivery system from alginates undergoing gelation in the eye [J].
Cohen, S ;
Lobel, E ;
Trevgoda, A ;
Peled, Y .
JOURNAL OF CONTROLLED RELEASE, 1997, 44 (2-3) :201-208